Smart dendrimers: Synergizing the targeting of anticancer bioactives

Vikrant Saluja, Abhinav Mankoo, Gaurav Saraogi, Murtaza M Tambuwala, Vijay Mishra

Research output: Contribution to journalArticle

Abstract

Optimization of biological performance of a carrier in cancer drug delivery depends on the targeting potential of the delivery system and its ability to control the drug release precisely. Dendrimers has emerged as a potential carrier of anticancer drugs due to some unique properties such as mono-dispersity, defined structure, amenability for functionalization using diverse ligands and its low-nanometer size. The dendrimers could be decorated to make them smart enough to carry the drug to the desired locus and release it in a controlled manner. The introduction of stimuli responsive functionality on dendrimers allows the release of payloads in response to a specific trigger only. These triggers could be endogenous in nature (acid, enzyme, and redox potentials) or it could be applied externally (light and temperature). These smart functionalities synergize the targeting of dendrimers and enable dendrimer-based anticancer drug delivery more efficient and safer. This review highlights the potential of stimuli responsive strategy for the controlled release of anticancer drug from dendritic assemblies.
LanguageEnglish
Article number52
Pages15-26
Number of pages12
JournalJournal of Drug Delivery Science and Technology
Volume52
Early online date16 Apr 2019
DOIs
Publication statusPublished - 1 Aug 2019

Fingerprint

Dendrimers
Pharmaceutical Preparations
Drug Carriers
Oxidation-Reduction
Ligands
Light
Temperature
Acids
Enzymes
Neoplasms

Keywords

  • Anticancer drug
  • Cancer
  • Dendrimers
  • Drug release
  • Drug targeting
  • Toxicity

Cite this

Saluja, Vikrant ; Mankoo, Abhinav ; Saraogi, Gaurav ; Tambuwala, Murtaza M ; Mishra, Vijay. / Smart dendrimers: Synergizing the targeting of anticancer bioactives. 2019 ; Vol. 52. pp. 15-26.
@article{b862bb108a5b453f9ef22fc8b4240219,
title = "Smart dendrimers: Synergizing the targeting of anticancer bioactives",
abstract = "Optimization of biological performance of a carrier in cancer drug delivery depends on the targeting potential of the delivery system and its ability to control the drug release precisely. Dendrimers has emerged as a potential carrier of anticancer drugs due to some unique properties such as mono-dispersity, defined structure, amenability for functionalization using diverse ligands and its low-nanometer size. The dendrimers could be decorated to make them smart enough to carry the drug to the desired locus and release it in a controlled manner. The introduction of stimuli responsive functionality on dendrimers allows the release of payloads in response to a specific trigger only. These triggers could be endogenous in nature (acid, enzyme, and redox potentials) or it could be applied externally (light and temperature). These smart functionalities synergize the targeting of dendrimers and enable dendrimer-based anticancer drug delivery more efficient and safer. This review highlights the potential of stimuli responsive strategy for the controlled release of anticancer drug from dendritic assemblies.",
keywords = "Anticancer drug, Cancer, Dendrimers, Drug release, Drug targeting, Toxicity",
author = "Vikrant Saluja and Abhinav Mankoo and Gaurav Saraogi and Tambuwala, {Murtaza M} and Vijay Mishra",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jddst.2019.04.014",
language = "English",
volume = "52",
pages = "15--26",

}

Smart dendrimers: Synergizing the targeting of anticancer bioactives. / Saluja, Vikrant ; Mankoo, Abhinav; Saraogi, Gaurav; Tambuwala, Murtaza M; Mishra, Vijay.

Vol. 52, 52, 01.08.2019, p. 15-26.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Smart dendrimers: Synergizing the targeting of anticancer bioactives

AU - Saluja, Vikrant

AU - Mankoo, Abhinav

AU - Saraogi, Gaurav

AU - Tambuwala, Murtaza M

AU - Mishra, Vijay

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Optimization of biological performance of a carrier in cancer drug delivery depends on the targeting potential of the delivery system and its ability to control the drug release precisely. Dendrimers has emerged as a potential carrier of anticancer drugs due to some unique properties such as mono-dispersity, defined structure, amenability for functionalization using diverse ligands and its low-nanometer size. The dendrimers could be decorated to make them smart enough to carry the drug to the desired locus and release it in a controlled manner. The introduction of stimuli responsive functionality on dendrimers allows the release of payloads in response to a specific trigger only. These triggers could be endogenous in nature (acid, enzyme, and redox potentials) or it could be applied externally (light and temperature). These smart functionalities synergize the targeting of dendrimers and enable dendrimer-based anticancer drug delivery more efficient and safer. This review highlights the potential of stimuli responsive strategy for the controlled release of anticancer drug from dendritic assemblies.

AB - Optimization of biological performance of a carrier in cancer drug delivery depends on the targeting potential of the delivery system and its ability to control the drug release precisely. Dendrimers has emerged as a potential carrier of anticancer drugs due to some unique properties such as mono-dispersity, defined structure, amenability for functionalization using diverse ligands and its low-nanometer size. The dendrimers could be decorated to make them smart enough to carry the drug to the desired locus and release it in a controlled manner. The introduction of stimuli responsive functionality on dendrimers allows the release of payloads in response to a specific trigger only. These triggers could be endogenous in nature (acid, enzyme, and redox potentials) or it could be applied externally (light and temperature). These smart functionalities synergize the targeting of dendrimers and enable dendrimer-based anticancer drug delivery more efficient and safer. This review highlights the potential of stimuli responsive strategy for the controlled release of anticancer drug from dendritic assemblies.

KW - Anticancer drug

KW - Cancer

KW - Dendrimers

KW - Drug release

KW - Drug targeting

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85064393469&partnerID=8YFLogxK

U2 - 10.1016/j.jddst.2019.04.014

DO - 10.1016/j.jddst.2019.04.014

M3 - Article

VL - 52

SP - 15

EP - 26

M1 - 52

ER -